Mental DisordersNCT01510080
Acceptance and Efficacy of Live Supervision
A study testing Computer-assisted live supervision and Delayed video-based supervision in people with Mental Disorders, run by Goethe University at 1 site in Germany.
Trial summary
In order to meet an existing lack of empirical studies in the field of cognitive behavioral therapy supervision, the present randomized controlled trial is aimed at comparing two different types of supervision. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Mental Disorders
- What is being tested?
- Computer-assisted live supervision and Delayed video-based supervision
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 1 siteGermany
- Study dates
- Jan 2012to Aug 2014
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Having successfully completed the interim audit
- Having started to treat ambulant patients under supervision
- Meeting ICD 10 criteria for a mental disorder
- Informed consent
Who cannot join
- -
- Patients
- Currently in psychotherapy
- Suicidal tendency
- Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder
Trial locations and contacts
1 site in 1 country.
Germany1 site
Department of Clinical Psychology and Psychotherapy of the Wolfgang Goethe University
Frankfurt am Main, Hesse, D-60486
About this study
Official title: Live Supervision Put to Test - Studies of Acceptance and Efficacy of Computer-assisted Live Supervision
In order to meet an existing lack of empirical studies in the field of cognitive behavioral therapy supervision, the present randomized controlled trial is aimed at comparing two different types of supervision. This study compares computer-assisted live supervision and delayed video-based supervision regarding efficacy and acceptance among therapists, patients and supervisors. The efficacy of supervision is defined on different levels such as change of psychotherapeutic competence, nondisclosure, self-efficacy, self-awareness of the supervisee as well as therapeutic alliance, supervisory alliance and therapy outcome.
- Conditions
- Mental Disorders
- Being tested
- Computer-assisted live supervision, Delayed video-based supervision
- Keywords
- Computer-assisted live supervision, "Bug-in-the-eye" supervision, Delayed video-based supervision, Cognitive behavioral therapy supervision
- Medical subject headings
- Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Computer-assisted live supervisionBehavioural
Also called "bug-in-the-eye" (BITE) supervision, video-based live supervision, monitor-based live supervision
8 BITE sessions, 4 video-based sessions (each 50 minutes) during treatment of 2 patients
Delayed video-based supervisionBehavioural
Also called videotape supervision
12 video-based sessions (each 50 minutes) during treatment of 2 patients
| Study group | Role | What they receive |
|---|---|---|
| Computer-assisted live supervision | Experimental | Supervisees assigned to this group will receive 8 sessions of computer-assisted live supervision and 4 sessions of delayed video-based supervision while treating 2 patients during 26 therapy sessions each. Computer-assisted live supervision is also known as "bug-in-the-eye" (BITE) supervision. The supervisor observes the therapy session with the help of a webcam and types messages on his computer. The instructions to the supervisee appear on a second monitor located in the therapy room where the supervisee can view it whenever he wants to. Receives: Behavioral: Computer-assisted live supervision |
| Delayed video-based supervision | Experimental | Supervisees assigned to this group will receive 12 sessions of delayed video-based supervision while treating 2 patients during 26 therapy sessions each. During delayed video-based supervision the supervisor and the supervisee spend 50 minutes reviewing selected parts of video recorded therapy sessions and discussing the case. Receives: Behavioral: Delayed video-based supervision |
What is being measured
The primary outcome is the main question the study is designed to answer.
Supervisory Questionnaire (SQ)
self-report measure that assesses nondisclosure of the supervisee during supervision
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Supervisee Levels Questionnaire (SLQ-R)
self-report measure that assesses self awareness, motivation and dependency- autonomy of supervisees
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Counseling Self-Estimate Inventory (COSE)
self-report measure that assesses self efficacy of the supervisee
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Fragebogen zur Psychotherapie-Supervision Kurzform (FSPT-K)
self-report measure that assesses level of development and supervision needs of the therapist
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Secondary outcomes (9)
Helping Alliance Questionnaire (HAQ)
self-report measure that assesses the therapeutic alliance
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Supervisory Working Alliance Inventory (SWAI)
self-report measure that assesses the supervisory relationship
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Beck-Depression Inventory II (BDI-II)
self-report measure that assesses depressive symptoms
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Beck Anxiety Inventory II (BAI)
self-report measure that asessses anxiety symptoms
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Brief Symptom Inventory (BSI)
self-report measure that assesses aspects of general psychopathology
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Health-related quality of life (SF-12)
self-report measure that assesses the health-related quality of life
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Client Satisfaction Questionnaire (CSQ8)
self-report measure that assesses satisfaction with therapy
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Stundenbogen zur Supervisionsbeurteilung (STEP SV)
self-report measure that assesses satisfaction with supervision
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Cognitive Therapy Scale (CTS)
clinician-rated measure that assesses psychotherapeutic competencies
Measured: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jan 2012 (estimated)
- Study startJan 2012
- Primary completionAug 2014
- Study completionAug 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mental DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- Goethe University
- Sponsor type
- University, hospital or other
- Collaborators
- Central Institute of Mental Health, Mannheim
- Responsible party
- Principal investigator, Florian Weck, Goethe University
- Investigators
- Florian Weck, PhD, Principal investigator, Goethe UniversityMartin Bohus, MD, Study director, Central Institute of Mental Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01510080
- Sponsor's protocol ID
- WECK-012
- Status last verified
- Jan 2015
- First submitted
- 12 Dec 2011
- Last updated
- 21 Jan 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Jan 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Live Supervision Put to Test - Studies of Acceptance and Efficacy of Computer-assisted Live Supervision
- ClinicalTrials.gov ID
- NCT01510080
- Acronym / sponsor ID
- WECK-012
- Conditions
- Mental Disorders
- Keywords
- Computer-assisted live supervision, "Bug-in-the-eye" supervision, Delayed video-based supervision, Cognitive behavioral therapy supervision
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 42 participants (actual)
- Lead sponsor
- Goethe UniversityUniversity, hospital or other
- Collaborators
- Central Institute of Mental Health, Mannheim
- Study start
- Jan 2012
- Primary completion
- Aug 2014 (actual)
- Study completion
- Aug 2014 (actual)
- First posted
- 13 Jan 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In order to meet an existing lack of empirical studies in the field of cognitive behavioral therapy supervision, the present randomized controlled trial is aimed at comparing two different types of supervision. This study compares computer-assisted live supervision and delayed video-based supervision regarding efficacy and acceptance among therapists, patients and supervisors. The efficacy of supervision is defined on different levels such as change of psychotherapeutic competence, nondisclosure, self-efficacy, self-awareness of the supervisee as well as therapeutic alliance, supervisory alliance and therapy outcome.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Computer-assisted live supervision | Experimental | Behavioral: Computer-assisted live supervisionSupervisees assigned to this group will receive 8 sessions of computer-assisted live supervision and 4 sessions of delayed video-based supervision while treating 2 patients during 26 therapy sessions each. Computer-assisted live supervision is also known as "bug-in-the-eye" (BITE) supervision. The supervisor observes the therapy session with the help of a webcam and types messages on his computer. The instructions to the supervisee appear on a second monitor located in the therapy room where the supervisee can view it whenever he wants to. |
| Delayed video-based supervision | Experimental | Behavioral: Delayed video-based supervisionSupervisees assigned to this group will receive 12 sessions of delayed video-based supervision while treating 2 patients during 26 therapy sessions each. During delayed video-based supervision the supervisor and the supervisee spend 50 minutes reviewing selected parts of video recorded therapy sessions and discussing the case. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Having successfully completed the interim audit
- Having started to treat ambulant patients under supervision
- Meeting ICD 10 criteria for a mental disorder
- Informed consent
Key exclusion criteria (5 listed)
- -
- Patients
- Currently in psychotherapy
- Suicidal tendency
- Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Computer-assisted live supervisionAlso: "bug-in-the-eye" (BITE) supervision, video-based live supervision, monitor-based live supervision8 BITE sessions, 4 video-based sessions (each 50 minutes) during treatment of 2 patients | Behavioural | Computer-assisted live supervision |
| Delayed video-based supervisionAlso: videotape supervision12 video-based sessions (each 50 minutes) during treatment of 2 patients | Behavioural | Delayed video-based supervision |
Primary outcome
Supervisory Questionnaire (SQ)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
self-report measure that assesses nondisclosure of the supervisee during supervision
Supervisee Levels Questionnaire (SLQ-R)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
self-report measure that assesses self awareness, motivation and dependency- autonomy of supervisees
Counseling Self-Estimate Inventory (COSE)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
self-report measure that assesses self efficacy of the supervisee
Fragebogen zur Psychotherapie-Supervision Kurzform (FSPT-K)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
self-report measure that assesses level of development and supervision needs of the therapist
9 secondary outcomes
Helping Alliance Questionnaire (HAQ)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Supervisory Working Alliance Inventory (SWAI)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Beck-Depression Inventory II (BDI-II)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Beck Anxiety Inventory II (BAI)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Brief Symptom Inventory (BSI)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Health-related quality of life (SF-12)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Client Satisfaction Questionnaire (CSQ8)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Stundenbogen zur Supervisionsbeurteilung (STEP SV)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Cognitive Therapy Scale (CTS)
Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jan 2015.
Related trials for Mental Disorders
Recruiting
The Trans-Led Care Study
Substance Abuse, Substance Addiction
Recruiting
Telehealth-Adapted Compensatory Training and Intervention for Cognition
MCI, Mild Cognitive Impairment
Active, not recruitingPhase 2
Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers
Arterial Stiffness, White Matter Lesions
Active, not recruiting
TMS-fNIRS Personalized Dosing
Post Traumatic Stress Disorder, Traumatic Brain Injury
RecruitingObservational study
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Alcoholism, Substance-Related Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Florian Weck, PhD principal investigator
Goethe University
Martin Bohus, MD study director
Central Institute of Mental Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Computer-assisted live supervision and Delayed video-based supervision in people with Mental Disorders, run by Goethe University at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Supervisory Questionnaire (SQ) (time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2015.